RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 2000; 83(04): 634-635
DOI: 10.1055/s-0037-1613879
DOI: 10.1055/s-0037-1613879
Letters to the Editor
Recombinant Factor VIIa for Bleeding in Refractory Thrombocytopenia
Weitere Informationen
Publikationsverlauf
Received
15. November 1999
Accepted
29. November 1999
Publikationsdatum:
08. Dezember 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/200004/lookinside/thumbnails/10-1055-s-0037-1613879-1.jpg)
-
References
- 1 Tengborn L, Petruson B. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant facor VIIa. Thromb Haemost 1996; 75: 981-2.
- 2 Peters M, Heijboer H. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost 1998; 80: 352.
- 3 Meijer K, Sieders E, Slooff MJH, de Wolf JTM, van der MEER J. Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII.
- 4 Revesz T, Arets B, Bierings M, van den Bos C. Recombinant factor VIIa in severe uremic bleeding. Thromb Haemost 1998; 80: 353.
- 5 Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist U, Johansson J, Glazer S, Hedner U. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26 (Suppl. 01) 159-64 6.
- 6 Weiss HJ, Lages B. Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood 1988; 71: 629-35.